Clinical implications of gene therapy for alpha1-antitrypsin deficiency

D. L. Knoell; M. D. Wewers

doi:10.1378/chest.107.2.535

Clinical implications of gene therapy for alpha₁-antitrypsin deficiency

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	535-545
Number of pages	11
Journal	Chest
Volume	107
Issue number	2
DOIs	https://doi.org/10.1378/chest.107.2.535
State	Published - 1995
Externally published	Yes

Keywords

delivery vectors
gene therapy
α-antitrypsin deficiency

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1378/chest.107.2.535

Cite this

@article{a5d5295862e44c49a9e637f1a064c3a2,

title = "Clinical implications of gene therapy for alpha1-antitrypsin deficiency",

keywords = "delivery vectors, gene therapy, α-antitrypsin deficiency",

author = "Knoell, {D. L.} and Wewers, {M. D.}",

year = "1995",

doi = "10.1378/chest.107.2.535",

language = "English (US)",

volume = "107",

pages = "535--545",

journal = "Chest",

issn = "0012-3692",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Clinical implications of gene therapy for alpha1-antitrypsin deficiency

AU - Knoell, D. L.

AU - Wewers, M. D.

PY - 1995

Y1 - 1995

KW - delivery vectors

KW - gene therapy

KW - α-antitrypsin deficiency

UR - http://www.scopus.com/inward/record.url?scp=0028873414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028873414&partnerID=8YFLogxK

U2 - 10.1378/chest.107.2.535

DO - 10.1378/chest.107.2.535

M3 - Article

C2 - 7842790

AN - SCOPUS:0028873414

SN - 0012-3692

VL - 107

SP - 535

EP - 545

JO - Chest

JF - Chest

IS - 2